Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial

Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial

Abstract Background Bronchopulmonary dysplasia (BPD) is still a common complication in very premature infants. At present, there is no effective treatment for BPD. Glucocorticoids are drugs commonly used to prevent or treat BPD before and after birth. In very premature infants with high risk factors...

Full description

Bibliographic Details
Main Authors: Yuan He, Yong Zhang, Shuqiang Gao, Xiaoling Wang, Na He, Deshuang Zhang, Wenbin Dong, Christian Wieg, Xiaoping Lei
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Trials
Subjects:
Bronchopulmonary dysplasia
Hydrocortisone
Preterm infants
Online Access:http://link.springer.com/article/10.1186/s13063-020-04698-0

Internet

http://link.springer.com/article/10.1186/s13063-020-04698-0

Similar Items